Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s40674-014-0005-0 http://scihub22266oqcxt.onion/10.1007/s40674-014-0005-0 C4437639!4437639!26005632     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Curr+Treatm+Opt+Rheumatol 2015 ; 1 (1): 82-105 Nephropedia Template TP {{tp|p=26005632|t=2015. Management of gastrointestinal involvement in scleroderma |pdf=|usr=}}{{26005632}} gab.com Text Management of gastrointestinal involvement in scleroderma JO: Curr Treatm Opt Rheumatol http://www.kidney.de/pget.php?&tw=1&pmid=26005632 #FOAvip Gastrointestinal tract (GIT) commonly affects patients with systemic sclerosis (SSc). The GI involvement is quite heterogeneous varying from asymptomatic disease to significant dysmotility causing complications like malabsorption, weight loss and severe malnutrition. This review focuses on the management of GI involvement in SSc and has been categorized based on the segment of GIT involved. A brief discussion on the role of patient reported outcome measures in SSc-GI involvement has also been incorporated. Twit Text FOAVip Management of gastrointestinal involvement in scleroderma ????Curr Treatm Opt Rheumatol http://www.kidney.de/pget.php?&tw=1&pmid=26005632 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26005632 #FOAvip English Wikipedia <ref>{{Cite pmid|26005632}}</ref> Management of gastrointestinal involvement in scleroderma #MMPMID26005632 Nagaraja V; McMahan ZH; Getzug T; Khanna D Curr Treatm Opt Rheumatol 2015[Mar]; 1 (1): 82-105 PMID26005632show ga Gastrointestinal tract (GIT) commonly affects patients with systemic sclerosis (SSc). The GI involvement is quite heterogeneous varying from asymptomatic disease to significant dysmotility causing complications like malabsorption, weight loss and severe malnutrition. This review focuses on the management of GI involvement in SSc and has been categorized based on the segment of GIT involved. A brief discussion on the role of patient reported outcome measures in SSc-GI involvement has also been incorporated. äManagement of gastrointestinal involvement in scleroderma (epmc).pdf DeepDyve Pubget Overpricing